Terms: = Pancreatic cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Staging
998 results:
1. Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer.
Tanemura M; Furukawa K; Mikamori M; Asaoka T; Yasuoka H; Marukawa D; Urata Y; Yamada D; Kobayashi S; Eguchi H
Sci Rep; 2024 May; 14(1):10199. PubMed ID: 38702437
[TBL] [Abstract] [Full Text] [Related]
2. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
[No Abstract] [Full Text] [Related]
3. Heterogeneous Uptake of 68 Ga-DOTATATE and 18 F-FDG in Initial Diagnosed Neuroendocrine Tumors Patients : Which Patients Are Suitable for Dual-Tracer PET Imaging?
Zhou Y; Li L; Wang H; Huang HX; Cao D; Ke NW; Su MG; Tian R
Clin Nucl Med; 2024 Jun; 49(6):516-520. PubMed ID: 38637950
[TBL] [Abstract] [Full Text] [Related]
4. Defining distal splenopancreatectomy by the mesopancreas.
Safi SA; Alexander A; Neuhuber W; Haeberle L; Rehders A; Luedde T; Esposito I; Fluegen G; Knoefel WT
Langenbecks Arch Surg; 2024 Apr; 409(1):127. PubMed ID: 38625602
[TBL] [Abstract] [Full Text] [Related]
5. Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study.
Liu D; Quan H; Ma M; Zhou H; Yang X; Wu Z; Luo J; Xiao H; Xiao Y
BMC Cancer; 2024 Mar; 24(1):344. PubMed ID: 38500085
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
[TBL] [Abstract] [Full Text] [Related]
7. Predicting the unpredictable: a robust nomogram for predicting recurrence in patients with ampullary carcinoma.
Chen R; Zhu L; Zhang Y; Cui D; Chen R; Guo H; Peng L; Xiao C
BMC Cancer; 2024 Feb; 24(1):212. PubMed ID: 38360582
[TBL] [Abstract] [Full Text] [Related]
8. Artificial intelligence to predict T4 stage of pancreatic ductal adenocarcinoma using CT imaging.
Miao Q; Wang X; Cui J; Zheng H; Xie Y; Zhu K; Chai R; Jiang Y; Feng D; Zhang X; Shi F; Tan X; Fan G; Liang K
Comput Biol Med; 2024 Mar; 171():108125. PubMed ID: 38340439
[TBL] [Abstract] [Full Text] [Related]
9. A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients.
Guo H; Li Y; Lin J; Li D; Yang J; Wang J; Mao J; Wang Y; Yan X
Int Immunopharmacol; 2024 Mar; 129():111611. PubMed ID: 38325047
[TBL] [Abstract] [Full Text] [Related]
10. Improved Clinical staging System for Localized pancreatic cancer Using the ABC Factors: A TAPS Consortium Study.
Dekker EN; van Dam JL; Janssen QP; Besselink MG; DeSilva A; Doppenberg D; van Eijck CHJ; Nasar N; O'Reilly EM; Paniccia A; Prakash LR; Tzeng CD; Verkolf EMM; Wei AC; Zureikat AH; Katz MHG; Groot Koerkamp B;
J Clin Oncol; 2024 Apr; 42(12):1357-1367. PubMed ID: 38315954
[TBL] [Abstract] [Full Text] [Related]
11. [Treatment Experience of Chemotherapy and Carbon-Ion Radiotherapy followed by Curative Conversion Surgery for Initially Locally Advanced Unresectable pancreatic cancer after Distal Gastrectomy].
Watanabe H; Sugawara S; Takahashi R; Ashitomi Y; Kawashiro S; Sato H; Nemoto K; Kono M; Futakuchi M; Motoi F
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1959-1961. PubMed ID: 38303264
[TBL] [Abstract] [Full Text] [Related]
12. Trends and disparities in access to minimally invasive distal pancreatectomy (midp): an eight-year analysis from the national cancer database.
Jehan FS; Khreiss M; Seth A; Aziz H
J Robot Surg; 2024 Jan; 18(1):52. PubMed ID: 38280048
[TBL] [Abstract] [Full Text] [Related]
13. Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective study.
Wang Y; Sun X; Chen C; Ge H; Sun J; Li E; Cai Z; Fu Q; Sun X; Wu J; Ye M; Cao W; Chen Q; Wei X; Han X; Sun K; Yan Q; Huang W; Wu L; Zeng Y; Zhang Q; Liang T
Cancer Lett; 2024 Mar; 585():216654. PubMed ID: 38272344
[TBL] [Abstract] [Full Text] [Related]
14. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma
Xu X; Wang MD; Xu JH; Fan ZQ; Diao YK; Chen Z; Jia HD; Liu FB; Zeng YY; Wang XM; Wu H; Qiu W; Li C; Pawlik TM; Lau WY; Shen F; Lv GY; Yang T
Front Immunol; 2023; 14():1322233. PubMed ID: 38268916
[TBL] [Abstract] [Full Text] [Related]
15. Development and validation of prealbumin-bilirubin score (preALBI score) for predicting long-term survival after hepatectomy for hepatocellular carcinoma: A multicenter analysis versus ALBI score.
Li C; Wang MD; Sun XD; Diao YK; Yao LQ; Wang H; Liang YJ; Zhou YH; Gu WM; Chen TH; Chen Z; Gu LH; Shen F; Lv GY; Yang T; Huang DS
Am J Surg; 2024 Jun; 232():87-94. PubMed ID: 38238192
[TBL] [Abstract] [Full Text] [Related]
16.
Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
[TBL] [Abstract] [Full Text] [Related]
17. Impact of Recombinant Granulocyte Colony-Stimulating Factor During Neoadjuvant Therapy on Outcomes of Resected pancreatic cancer.
Murthy P; Zenati MS; AlMasri SS; DeSilva A; Singhi AD; Paniccia A; Lee KK; Simmons RL; Bahary N; Lotze MT; Zureikat AH
J Natl Compr Canc Netw; 2023 Dec; 22(1D):e237070. PubMed ID: 38150819
[TBL] [Abstract] [Full Text] [Related]
18. Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms.
Beck J; Siebenhüner A; Wild D; Christ E; Refardt J
Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38117915
[TBL] [Abstract] [Full Text] [Related]
19. Inadequacy of the eighth edition of the American Joint Committee on cancer pancreatic cancer staging system for invasive carcinoma associated with premalignant lesions in the pancreas: an analysis using the National cancer Database.
Jung HS; Lee M; Han Y; Thomas AS; Yun WG; Cho YJ; Kluger MD; Jang JY; Kwon W
HPB (Oxford); 2024 Mar; 26(3):400-409. PubMed ID: 38114399
[TBL] [Abstract] [Full Text] [Related]
20. Combined utility of Ki-67 index and tumor grade to stratify patients with pancreatic ductal adenocarcinoma who underwent upfront surgery.
Li B; Yin X; Ding X; Zhang G; Jiang H; Chen C; Guo S; Jin G
BMC Surg; 2023 Dec; 23(1):370. PubMed ID: 38066512
[TBL] [Abstract] [Full Text] [Related]
[Next]
